Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 201

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis

Open access
Hoofnagle, J. H., Van Natta, M. L., Kleiner, D. E., Clark, J. M., Kowdley, K. V., Loomba, R., Neuschwander‐Tetri, B. A., Sanyal, A. J., Tonascia, J., the Non‐alcoholic Steatohepatitis Clinical Research Network (NASH CRN) · 2013 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Non‐alcoholic steatohepatitis (NASH) is a common cause of serum alanine aminotransferase (ALT) elevations and chronic liver disease, but it is unclear how well ALT elevations reflect the liver injury. Aim: To assess how well changes in ALT elevations reflect improvements in liver histology in response to vitamin E therapy. Methods: The vitamin E and placebo arms of the Pi oglitazone vs. V itamin E vs. Placebo in N on‐alcoholic S teatohepatitis (PIVENS) trial were reassessed for associations among changes in ALT levels, body weight and liver histology. An ALT response was defined as a decrease to ≤40 U/L and by ≥30% of baseline. Liver biopsies taken before and after treatment were scored for non‐alcoholic fatty liver disease activity (NAS) and fibrosis. Results: ALT responses were more frequent among vitamin E (48%) than placebo (16%) recipients (P < 0.001). Among vitamin E recipients, ALT responses were associated with decreases in NAS (P < 0.001), but not fibrosis scores (P = 0.34), whereas among placebo recipients, ALT responses were associated with significant decreases in both (P < 0.05). Weight loss (≥2 kg) was also associated with ALT response (P < 0.001), improvements in NAS (P < 0.001) and fibrosis (P < 0.02), but vitamin E had an added effect both with and without weight loss. Weight gain (≥2 kg) was associated with lack of ALT response and worsening NAS and fibrosis scores in patients not on vitamin E. Conclusions: Decrease of ALT levels to normal in patients with NASH is usually associated with improved histological activity. Management should stress the value of weight loss and strongly discourage weight gain. Vitamin E can improve both ALT levels and histology with and without weight loss. Clinical Trial Number: NCT00063622.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.12352

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. 10.1016/0016-5085(92)90344-X · DOI
  2. Tanyel MC, 1997, Neurologic findings in vitamin E deficiency, Am Fam Physician, 55, 197
  3. 10.1093/ajcn/41.1.66 · DOI
  4. 10.1001/jama.2008.864 · DOI · Paper page
  5. 10.1001/jama.2008.862 · DOI · Paper page
  6. 10.1016/S0022-3476(00)05040-X · DOI · Paper page
  7. 10.1016/S1542-3565(04)00457-4 · DOI · Paper page
  8. 10.1001/jama.2011.520 · DOI · Paper page
  9. 10.1016/j.cct.2008.09.003 · DOI · Paper page
  10. 10.1002/hep.1840120505 · DOI · Paper page
  11. 10.1053/j.gastro.2010.09.038 · DOI · Paper page
  12. 10.1111/j.1365-2036.2011.04724.x · DOI · Paper page
  13. 10.1111/j.1365-2036.2008.03703.x · DOI
  14. 10.1016/j.cgh.2008.11.005 · DOI · Paper page
  15. 10.1002/hep.21327 · DOI · Paper page
  16. 10.1002/hep.23314 · DOI · Paper page
  17. 10.1053/j.gastro.2011.06.061 · DOI · Paper page
  18. 10.1002/hep.23784 · DOI · Paper page
  19. 10.1111/j.1365-2036.2008.03896.x · DOI

Cited by

See all 201

Metadata

Authors
Hoofnagle, J. H., Van Natta, M. L., Kleiner, D. E., Clark, J. M., Kowdley, K. V., Loomba, R., Neuschwander‐Tetri, B. A., Sanyal, A. J., Tonascia, J., & the Non‐alcoholic Steatohepatitis Clinical Research Network (NASH CRN)
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2013-05-29
Volume
38
Issue
2
Pages
134-143
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2054305537
Cited by
201
References
8
FWCI
12.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.